Krystal Biotech KRYS
NASDAQ KRYS
$334.07 -0.99 (-0.30%)
As of: Sep 30, 2026 · 2:10 PM EDT

Krystal Biotech, Inc. (KRYS) Revenue (2023 - 2026)

Updated

Krystal Biotech (KRYS) recorded Revenue of $119.22 million in Q2 2026, up 24.1% from $96.04 million a year earlier and up 2.4% from the prior quarter.

Analysis

Krystal Biotech, Inc. (KRYS) Revenue (2023 - 2026) Analysis & Trends

On a TTM basis, Krystal Biotech's Revenue came in at $440.53 million as of Jun 30, 2026, up 22.6% year-over-year; for FY2025, it came in at $389.13 million, up 33.9% from FY2024.

  • Across earlier years, Revenue came in at $290.52 million in FY2024 (+473.0%) and $50.7 million in FY2023.
  • The Q2 2026 figure is the highest quarterly Revenue in data going back to Q3 2023.
  • On a year-over-year basis, Revenue has increased for eight consecutive quarters, with growth averaging 152.2% over the last eight quarters.
  • The year-over-year growth in Revenue has ranged between 16.6% (Q3 2025) and 879.9% (Q3 2024) over the last five years.
  • Per Business Quant, the preceding three quarters came in at $116.4 million (Q1 2026), $107.11 million (Q4 2025) and $97.8 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 119.22 Mn
Mar 31, 2026 116.40 Mn
Dec 31, 2025 107.11 Mn
Sep 30, 2025 97.80 Mn
Jun 30, 2025 96.04 Mn
Mar 31, 2025 88.20 Mn
Dec 31, 2024 91.12 Mn
Sep 30, 2024 83.84 Mn
Jun 30, 2024 70.30 Mn
Mar 31, 2024 45.30 Mn
Dec 31, 2023 42.14 Mn
Sep 30, 2023 8.56 Mn
API Access

Krystal Biotech, Inc. Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=KRYS&period=max&api_key=YOUR_API_KEY